Sodium phenylbutyrate

Phase 2

00%

Phase 2

Development Phase

Upcoming Catalysts

Historical Events

Regulatory Approvals

Upcoming Catalysts

Jan '27

ZVRAPhase 2$663M

Sodium phenylbutyrate Phase 2 Est. Readout

Sodium phenylbutyrate• Medium-chain Acyl-CoA Dehydrogenase Deficiency24

Jan 2027~Confirmed

00%

Competitive Landscape

0 competitors in Medium-chain Acyl-CoA Dehydrogenase Deficiency

Drug Information

Target Indication

Medium-chain Acyl-CoA Dehydrogenase Deficiency

Clinical Trial

Last updated: 10/17/2026

Patent & Exclusivity

No patent data available. Pre-approval drugs may not have Orange Book listings.

Drug Science

Mechanism of action & safety profile

Developer

ZVRA

ZEVRA THERAPEUTICS, INC.

Related Pipeline

ADHD

Idiopathic Hypersomnia

Get Catalyst Alerts

Receive weekly digests of upcoming catalysts